213 related articles for article (PubMed ID: 17881734)
21. Role of dystroglycan in limiting contraction-induced injury to the sarcomeric cytoskeleton of mature skeletal muscle.
Rader EP; Turk R; Willer T; Beltrán D; Inamori K; Peterson TA; Engle J; Prouty S; Matsumura K; Saito F; Anderson ME; Campbell KP
Proc Natl Acad Sci U S A; 2016 Sep; 113(39):10992-7. PubMed ID: 27625424
[TBL] [Abstract][Full Text] [Related]
22. Perlecan and Dystroglycan act at the basal side of the Drosophila follicular epithelium to maintain epithelial organization.
Schneider M; Khalil AA; Poulton J; Castillejo-Lopez C; Egger-Adam D; Wodarz A; Deng WM; Baumgartner S
Development; 2006 Oct; 133(19):3805-15. PubMed ID: 16943280
[TBL] [Abstract][Full Text] [Related]
23. Role of N-glycans in maintaining the activity of protein O-mannosyltransferases POMT1 and POMT2.
Manya H; Akasaka-Manya K; Nakajima A; Kawakita M; Endo T
J Biochem; 2010 Mar; 147(3):337-44. PubMed ID: 19880378
[TBL] [Abstract][Full Text] [Related]
24. Increased apoptosis of myoblasts in Drosophila model for the Walker-Warburg syndrome.
Ueyama M; Akimoto Y; Ichimiya T; Ueda R; Kawakami H; Aigaki T; Nishihara S
PLoS One; 2010 Jul; 5(7):e11557. PubMed ID: 20644630
[TBL] [Abstract][Full Text] [Related]
25. The expanding phenotype of POMT1 mutations: from Walker-Warburg syndrome to congenital muscular dystrophy, microcephaly, and mental retardation.
van Reeuwijk J; Maugenre S; van den Elzen C; Verrips A; Bertini E; Muntoni F; Merlini L; Scheffer H; Brunner HG; Guicheney P; van Bokhoven H
Hum Mutat; 2006 May; 27(5):453-9. PubMed ID: 16575835
[TBL] [Abstract][Full Text] [Related]
26. POMT2, a key enzyme in Walker-Warburg syndrome: somatic sPOMT2, but not testis-specific tPOMT2, is crucial for mannosyltransferase activity in vivo.
Lommel M; Willer T; Strahl S
Glycobiology; 2008 Aug; 18(8):615-25. PubMed ID: 18490429
[TBL] [Abstract][Full Text] [Related]
27. Large induces functional glycans in an O-mannosylation dependent manner and targets GlcNAc terminals on alpha-dystroglycan.
Hu Y; Li ZF; Wu X; Lu Q
PLoS One; 2011 Feb; 6(2):e16866. PubMed ID: 21347376
[TBL] [Abstract][Full Text] [Related]
28. Dystroglycan and mitochondrial ribosomal protein L34 regulate differentiation in the Drosophila eye.
Zhan Y; Melian NY; Pantoja M; Haines N; Ruohola-Baker H; Bourque CW; Rao Y; Carbonetto S
PLoS One; 2010 May; 5(5):e10488. PubMed ID: 20463973
[TBL] [Abstract][Full Text] [Related]
29. Whoa man! Unexpected protein
Sheikh MO; Wells L
J Biol Chem; 2017 Jul; 292(27):11599-11600. PubMed ID: 28687598
[TBL] [Abstract][Full Text] [Related]
30. Dystroglycanopathy with two novel POMT1 mutations in a Chinese boy with developmental delay and muscular dystrophy.
Chong YK; Ma LC; Lo KL; Lee CK; Mak CM; Kan AN; Lam CW
Eur J Paediatr Neurol; 2014 Jul; 18(4):532-5. PubMed ID: 24657014
[TBL] [Abstract][Full Text] [Related]
31. Congenital muscular dystrophy with glycosylation defects of alpha-dystroglycan in Japan.
Matsumoto H; Hayashi YK; Kim DS; Ogawa M; Murakami T; Noguchi S; Nonaka I; Nakazawa T; Matsuo T; Futagami S; Campbell KP; Nishino I
Neuromuscul Disord; 2005 May; 15(5):342-8. PubMed ID: 15833426
[TBL] [Abstract][Full Text] [Related]
32. POMT1 and POMT2 gene mutations result in 2 cases of
Gan S; Yang H; Xiao T; Pan Z; Wu L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 46(8):915-919. PubMed ID: 34565739
[TBL] [Abstract][Full Text] [Related]
33. Hypoglycosylation of dystroglycan due to T192M mutation: a molecular insight behind the fact.
Bhattacharya S; Das A; Ghosh S; Dasgupta R; Bagchi A
Gene; 2014 Mar; 537(1):108-14. PubMed ID: 24361964
[TBL] [Abstract][Full Text] [Related]
34. Protein O-mannosyltransferase activities in lymphoblasts from patients with alpha-dystroglycanopathies.
Manya H; Bouchet C; Yanagisawa A; Vuillaumier-Barrot S; Quijano-Roy S; Suzuki Y; Maugenre S; Richard P; Inazu T; Merlini L; Romero NB; Leturcq F; Bezier I; Topaloglu H; Estournet B; Seta N; Endo T; Guicheney P
Neuromuscul Disord; 2008 Jan; 18(1):45-51. PubMed ID: 17869517
[TBL] [Abstract][Full Text] [Related]
35. Dolichol-phosphate mannose synthase depletion in zebrafish leads to dystrophic muscle with hypoglycosylated α-dystroglycan.
Marchese M; Pappalardo A; Baldacci J; Verri T; Doccini S; Cassandrini D; Bruno C; Fiorillo C; Garcia-Gil M; Bertini E; Pitto L; Santorelli FM
Biochem Biophys Res Commun; 2016 Aug; 477(1):137-143. PubMed ID: 27291147
[TBL] [Abstract][Full Text] [Related]
36. Drosophila miR-9a targets the ECM receptor Dystroglycan to canalize myotendinous junction formation.
Yatsenko AS; Shcherbata HR
Dev Cell; 2014 Feb; 28(3):335-48. PubMed ID: 24525189
[TBL] [Abstract][Full Text] [Related]
37. Milder phenotype of congenital muscular dystrophy in a novel POMT1 mutation.
Al-Zaidy SA; Baskin B; Hawkins C; Yoon G; Ray PN; Vajsar J
Muscle Nerve; 2012 May; 45(5):752-5. PubMed ID: 22499106
[TBL] [Abstract][Full Text] [Related]
38. POMGnT1, POMT1, and POMT2 mutations in congenital muscular dystrophies.
Endo T; Manya H; Seta N; Guicheney P
Methods Enzymol; 2010; 479():343-52. PubMed ID: 20816175
[TBL] [Abstract][Full Text] [Related]
39. Genetic modifier screens reveal new components that interact with the Drosophila dystroglycan-dystrophin complex.
Kucherenko MM; Pantoja M; Yatsenko AS; Shcherbata HR; Fischer KA; Maksymiv DV; Chernyk YI; Ruohola-Baker H
PLoS One; 2008 Jun; 3(6):e2418. PubMed ID: 18545683
[TBL] [Abstract][Full Text] [Related]
40. Protein O-mannosylation in animal development and physiology: from human disorders to Drosophila phenotypes.
Nakamura N; Lyalin D; Panin VM
Semin Cell Dev Biol; 2010 Aug; 21(6):622-30. PubMed ID: 20362685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
